Axonics, Inc. (AXNX)
AXNX moved a median of +0.01% 30 minutes after news, and +0.19% by the close. How AXNX actually reacts to news — the realized, point-in-time move the market made, measured across 99 labeled events over the last three years with zero look-ahead.
AXNX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 44% | 80 |
| 30-min | +0.01% | 51% | 80 |
| 60-min | +0.05% | 54% | 80 |
| to close | +0.19% | 64% | 80 |
| Middle 50% of AXNX reactions | -0.13% to +0.19% |
|---|---|
| Median reaction (30-min) | +0.01% |
| Measured reactions | 99 |
Half of all Axonics, Inc. news events land between -0.13% and +0.19% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How AXNX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 18 | -0.20% | 22% | -0.10% |
| Rating reiterations | 19 | +0.07% | 68% | +0.16% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how AXNX ranks against every other measured name →
That’s how AXNX usually reacts — get an email when it moves on news →Email me when AXNX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to AXNX's baseline. Nothing else.
Recent AXNX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors | Press release | Business Wire | — | — | |
| Form 15-12G Axonics, Inc. | SEC filing · Form 15-12G | SEC EDGAR | — | — | |
| Form EFFECT Axonics, Inc. | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Form 8-K Axonics, Inc. For: Nov 15 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form POS AM Axonics, Inc. | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form S-8 POS Axonics, Inc. | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Axonics Reports Third Quarter 2024 Financial Results | Press release | Business Wire | -0.06% | -0.09% | |
| Form 10-Q Axonics, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.06% | -0.09% | |
| Form 8-K Axonics, Inc. For: Nov 07 | SEC filing · Form 8-K | SEC EDGAR | -0.06% | -0.09% | |
| Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia | Press release | Business Wire | -0.36% | -0.54% | |
| Axonics Prevails in Patent Infringement Lawsuit with Medtronic | Press release | Business Wire | -0.03% | -0.01% | |
| Axonics Reports Second Quarter 2024 Financial Results | Press release | Business Wire | +0.10% | +0.13% | |
| Form 10-Q Axonics, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.10% | +0.13% | |
| Form 8-K Axonics, Inc. For: Aug 01 | SEC filing · Form 8-K | SEC EDGAR | +0.10% | +0.13% | |
| Kestra Medical Technologies Announces Appointment of Veteran Medical Device Executive, Raymond W. Cohen, to its Board of Directors | Press release | Business Wire | -0.06% | +0.28% | |
| Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia | Press release | Business Wire | -0.55% | -0.31% | |
| Axonics Reports First Quarter 2024 Financial Results | Press release | Business Wire | +0.00% | +0.56% | |
| Form 10-Q Axonics, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.56% | |
| Form 8-K Axonics, Inc. For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.56% | |
| Form 10-K/A Axonics, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.12% | -0.28% | |
| Form 8-K Axonics, Inc. For: Apr 03 | SEC filing · Form 8-K | SEC EDGAR | +0.44% | +0.24% | |
| Form 8-K Axonics, Inc. For: Mar 22 | SEC filing · Form 8-K | SEC EDGAR | +0.14% | +0.30% | |
| Axonics Stockholders Approve Merger Agreement with Boston Scientific | Press release | Business Wire | +0.12% | +0.44% | |
| Axonics Provides Update on Inter Partes Review Proceedings | Press release | Business Wire | +0.04% | -0.35% | |
| Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System | Press release | Business Wire | +0.28% | +0.07% | |
| Form DEFA14A Axonics, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.18% | +0.33% | |
| Axonics Responds to ITC Action by Medtronic | Press release | Business Wire | -0.23% | -0.38% | |
| Form 10-K Axonics, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.19% | -0.53% | |
| Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results | Press release | Business Wire | -1.19% | -0.53% | |
| Form 8-K Axonics, Inc. For: Feb 28 | SEC filing · Form 8-K | SEC EDGAR | -1.19% | -0.53% | |
| SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AXNX, KAMN, JNPR, AVRO | Press release | GlobeNewswire | +0.01% | +0.32% | |
| SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AXNX, JNPR, MDC | Press release | PR Newswire | +0.02% | +0.03% | |
| SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AXNX, KAMN, BATL, JNPR | Press release | GlobeNewswire | +0.12% | +0.62% | |
| Form DEFM14A Axonics, Inc. | SEC filing · Form DEFM14A | SEC EDGAR | +0.04% | +0.40% | |
| SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AXNX, PGTI, EGLE, BBAI | Press release | GlobeNewswire | +0.03% | -0.07% | |
| Form PREM14A Axonics, Inc. For: Feb 06 | SEC filing · Form PREM14A | SEC EDGAR | -0.47% | -0.59% | |
| SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VIA, FGH, AXNX | Press release | GlobeNewswire | +0.03% | -0.15% | |
| SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates AXNX, AMAM, HARP | Press release | Accesswire | -0.04% | -0.28% | |
| ALERT: Juan Monteverde Encourages the Shareholders of AXNX, BVH, GRCL, CVLY to Take Action | Press release | GlobeNewswire | +0.00% | -0.26% | |
| ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc. | Press release | PR Newswire | -0.13% | +0.19% | |
| AXNX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Axonics to Boston Scientific | Press release | GlobeNewswire | -0.07% | +0.52% | |
| AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders | Press release | Business Wire | -0.07% | +0.52% | |
| Axonics Announces Definitive Agreement to be Acquired by Boston Scientific | Press release | Business Wire | -0.07% | +0.52% | |
| Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue | Press release | Business Wire | -0.07% | +0.52% | |
| Form 8-K Axonics, Inc. For: Jan 08 | SEC filing · Form 8-K | SEC EDGAR | -0.07% | +0.52% | |
| Form DEF 14A Axonics, Inc. For: Jan 08 | SEC filing · Form DEF | SEC EDGAR | -0.13% | +0.19% | |
| SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX, EAR | Press release | GlobeNewswire | -0.13% | +0.19% | |
| Axonics to Present at the J.P. Morgan Healthcare Conference | Press release | Business Wire | -0.19% | +1.19% | |
| BiVACOR Appoints Veteran Medical Device Executive Raymond W. Cohen as Chairman of the Board of Directors | Press release | Business Wire | +0.00% | +1.55% | |
| Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities | Press release | GlobeNewswire | +0.26% | -1.02% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AXNX section they belong to.
Where else AXNX is measured.
AXNX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Mynd.ai, Inc. American Depositary Shares (MYND) | 100 | +0.52% | 58% |
| ARCA biopharma, Inc. (ABIO) | 99 | 0.00% | 48% |
| Novo Integrated Sciences, Inc. (NVOS) | 99 | 0.00% | 42% |
| Pulmatrix, Inc. (PULM) | 99 | +0.18% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Axonics, Inc.'s median reaction calculated?
Every labeled AXNX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 99 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of AXNX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does AXNX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.